These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 17177190

  • 1. Late onset membranous nephropathy complicating donor lymphocyte infusion for leukaemia relapse after allogeneic stem cell transplantation.
    Lam MF, Au WY, Tse KC, Chan TM, Chan GS, Chan KW, Lai KN.
    Am J Hematol; 2007 Apr; 82(4):327-8. PubMed ID: 17177190
    [No Abstract] [Full Text] [Related]

  • 2. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
    Chiorean EG, DeFor TE, Weisdorf DJ, Blazar BR, McGlave PB, Burns LJ, Brown C, Miller JS.
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):171-7. PubMed ID: 14993882
    [Abstract] [Full Text] [Related]

  • 3. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I, Miyamura K, Yamada M, Sasaki O, Harigae H, Kameoka J, Meguro K, Sasaki T.
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [Abstract] [Full Text] [Related]

  • 4. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B, Bogunia-Kubik K, Dlubek D, Jaskula E, Sok A, Drabczak-Skrzypek D, Sedzimirska M, Lange A.
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [Abstract] [Full Text] [Related]

  • 5. Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion.
    Levenga H, Woestenenk R, Schattenberg AV, Maas F, Jansen JH, Raymakers R, De Mulder PH, van de Wiel-van Kemenade E, Schaap N, de Witte T, Dolstra H.
    Bone Marrow Transplant; 2007 Sep; 40(6):585-92. PubMed ID: 17637687
    [Abstract] [Full Text] [Related]

  • 6. Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment.
    Dazzi F, Fozza C.
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):311-27. PubMed ID: 17448964
    [Abstract] [Full Text] [Related]

  • 7. Recurrent nephrotic syndrome associated with graft-versus-host disease.
    Ikee R, Yamamoto K, Kushiyama T, Imakiire T, Suzuki S, Miura S.
    Bone Marrow Transplant; 2004 Dec; 34(11):1005-6. PubMed ID: 15489871
    [No Abstract] [Full Text] [Related]

  • 8. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.
    Ruiz-Argüelles GJ, Gómez-Almaguer D, López-Martínez B, Cantú-Rodríguez OG, Jaime-Pérez JC, González-Llano O.
    Haematologica; 2002 Aug; 87(8):894-6. PubMed ID: 12161373
    [No Abstract] [Full Text] [Related]

  • 9. A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation.
    Lutz C, Massenkeil G, Nagy M, Neuburger S, Tamm I, Rosen O, Dörken B, Arnold R.
    Bone Marrow Transplant; 2008 May; 41(9):805-12. PubMed ID: 18195682
    [Abstract] [Full Text] [Related]

  • 10. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R, Remberger M, Cederlund K, Ringdén O, Barkholt L.
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [Abstract] [Full Text] [Related]

  • 11. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
    Nouri-Majelan N, Sanadgol H, Ghafari A, Rahimian M, Najafi F, Mortazavizadeh M, Moghaddasi S.
    Transplant Proc; 2005 Sep; 37(7):3213-5. PubMed ID: 16213351
    [Abstract] [Full Text] [Related]

  • 12. Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
    Barbara JA, Thomas AC, Smith PS, Gillis D, Ho JO, Woodroffe AJ.
    Clin Nephrol; 1992 Mar; 37(3):115-8. PubMed ID: 1563114
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Transient nephrotic syndrome after allogeneic bone marrow transplantation for chronic myelogenous leukemia].
    Ishizuka Y, Yokota A, Hara S, Nakaseko C, Matsuura Y, Nishimura M, Saitoh Y.
    Rinsho Ketsueki; 2001 Apr; 42(4):321-7. PubMed ID: 11400304
    [Abstract] [Full Text] [Related]

  • 16. Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion.
    Amrolia PJ, Rao K, Slater O, Ramsay A, Veys PA, Webb DK.
    Bone Marrow Transplant; 2001 Sep; 28(6):623-5. PubMed ID: 11607779
    [Abstract] [Full Text] [Related]

  • 17. Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion.
    Skert C, Patriarca F, Zaja F, Tomadini V, Fanin R.
    Bone Marrow Transplant; 2005 Mar; 35(5):523-4. PubMed ID: 15654352
    [No Abstract] [Full Text] [Related]

  • 18. Rituximab in membranous nephropathy after haematopoietic stem cell transplantation.
    Ferrannini M, Vischini G, Di Daniele N.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2700-1; author reply 2701. PubMed ID: 18385388
    [No Abstract] [Full Text] [Related]

  • 19. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E, Koza V, Vítek A, Mayer J, Sedlácek P, Zák P, Zapletalová J, Benesová K, Krejcová H, Steinerová K, Maresová I, Cetkovský P.
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [Abstract] [Full Text] [Related]

  • 20. Splenectomy status of the patient may have impact on response to donor lymphocyte infusions.
    Uckan-Cetinkaya D, Unal S, Cetin M, Sarikabadayi U, Aktaş D, Koç Y.
    Leukemia; 2007 Sep; 21(9):2049-50; author reply 2050-1. PubMed ID: 17554372
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.